Novozymes A/S (NVZMY)
| Previous close | 68.62 |
| Open | 69.11 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 69.11 - 70.45 |
| 52-week range | 54.55 - 81.35 |
| Volume | 8,265 |
| Avg. volume | 7,983 |
| Market cap | 39.249B |
| Beta (5Y monthly) | 0.27 |
| PE ratio (TTM) | 42.55 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.84 (1.10%) |
| Ex-dividend date | 12 Mar 2021 |
| 1y target est | N/A |
- Globe Newswire
Novozymes is unlocking growth with the ambition of doubling company revenue by 2030
With the launch of “Unlocking Growth – Powered by Biotech” Novozymes presents its 2025-strategy. It sets out an organic sales growth target of 5+% CAGR for the 5-year period until 2025, coupled with the ambition to double the company’s revenue by 2030. COPENHAGEN, DENMARK – 27 September 2021 – “Unlocking Growth – Powered by Biotech” is Novozymes’ strategy towards 2025 based on the solid foundation and successful execution of “Better Business with Biology”. As part of ‘Unlocking Growth’ Novozymes
- Globe Newswire
Novozymes announces its 2025 strategy: Unlocking growth – powered by biotech
Please read the full announcement in PDF Attachment 2021_46_Novozymes_announces_ 2025_strategy
- Globe Newswire
Novozymes is combining cutting-edge science and business expertise to help feed the world sustainably
To feed a growing population, Novozymes is inviting all interested parties to help co-create and innovate the future of sustainable protein. By combining science with business expertise Novozymes wants to rethink how protein is made and sourced by enabling a new and progressive industry to provide sustainable nutrition. COPENHAGEN, DENMARK – 21 September, 2021 – As the U.N. Food System Summit sets the stage to bring about tangible, positive changes to the world’s food systems, Novozymes, the wor
